Warning
MICRO LABS USA INC Recalls Dorzolamide HCl and Timolol Maleate Ophthalmic Solution
This is a Class II recall. This product may cause temporary health problems or pose a slight threat of a serious nature.
Source: FDA
WarningRecall #D-0730-2026Drug / Pharmaceutical
MICRO LABS USA INC Recalls Dorzolamide HCl and Timolol Maleate Ophthalmic Solution
MICRO LABS USA INC · Class II — Moderate Risk
Product Description
Dorzolamide HCl and Timolol Maleate Ophthalmic Solution, USP, 2%/0.5%, 10mL - bottle, Rx only, Manufactured by: Micro Labs Limited, India, Manufactured for: Micro Labs USA Inc., Somerset, NJ 08873. NDC 42571-147-26.
Reason for Recall
Defective Container: Firm received multiple complaints of broken cap spikes and undeliverable drops.
FDA Classification
Class II — Moderate Risk
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Distribution
Nationwide in the USA.
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
MICRO LABS USA INC has recalled a pharmaceutical product that the FDA classified as Class II. The recall was initiated on July 22, 2026. Defective Container: Firm received multiple complaints of broken cap spikes and undeliverable drops. It was distributed nationwide. Class II recalls involve products that might cause a temporary health problem or pose only a slight threat of a serious nature. Consumers should discontinue use and contact the firm.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medication Defects.